Am I eligible for the program?
You may be eligible for our free prescription program if you meet the requirements below:
- You have been prescribed a Johnson & Johnson operating company donated medication
- You meet the eligibility income requirements for the medication(s). You may view the income requirements below
- You don’t have insurance or medicine is not covered
- Some patients with Medicare Prescription Drug Coverage (Part D) who cannot afford their medicines and who meet certain financial criteria may also be eligible for assistance
- A report from your pharmacy or an Explanation of Benefits (EOB) statement from your insurer that shows your out-of-pocket costs for the current year can be requested and may be submitted with your application. In order to qualify for the program, you must spend 4% or more of your gross annual income on prescription drugs.
- You live in the United States or a U.S. Territory
- You are being treated by a U.S. licensed doctor as an outpatient
BALVERSA™
(erdafitinib) Tablets
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
CONCERTA® †
(methylphenidate HCI) Extended-Release Tablets CII
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
DARZALEX®
(daratumumab) Injection for intravenous infusion
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
EDURANT® 1
(rilpivirine) Tablets
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
ELMIRON®
(pentosan polysulfate sodium) Capsules
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
ERLEADA®
(apalutamide) Tablets
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
HALDOL® †
(haloperidol) Immediate-Release Injection
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
HALDOL® Decanoate†
(haloperidol) IM Injection Only
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
IMBRUVICA®
(ibrutinib) Capsules/Tablets
$74,940
$101,460
$127,980
$154,500
$181,020
Variable – please call us for more information
INTELENCE® 1
(etravirine) Tablets
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
INVEGA SUSTENNA® †
(paliperidone palmitate) Extended-Release Injectable Suspension
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
INVEGA TRINZA®†
(paliperidone palmitate) Extended-Release Injectable Suspension
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
INVOKAMET®† 1
(canagliflozin/metformin HCI) Tablets
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
INVOKAMET® XR† 1
(canagliflozin/metformin HCI) Tablets
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
INVOKANA®† 1
(canagliflozin) Tablets
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
MONOVISC®
(high molecular weight hyaluronan) Injection
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
ORTHOVISC®
(high molecular weight hyaluronan) Injection
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
PREZCOBIX®1
(darunavir 800mg/cobicistat 150mg) Tablets
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
PREZISTA® 1
(darunavir) Tablets/Oral Suspension
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
PROCRIT® †
(epoetin alfa) Injection
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
REMICADE® †
(infliximab) IV Infusion
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
RISPERDAL CONSTA® †
(risperidone) Long-Acting Injection
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
SIMPONI® †
(golimumab) Injection
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
SIMPONI ARIA®†
(golimumab) IV Infusion
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
SIRTURO®
(bedaquiline) Tablets
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
SPORANOX® †
(itraconazole) Capsules
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
SPORANOX® †
(itraconazole) Oral Solution
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
SPRAVATO™ †
(esketamine) Nasal Spray, for intranasal use, CIII
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
STELARA®
(ustekinumab) Injection, for subcutaneous or intravenous use
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
SYMTUZA®
(darunavir, cobicistat, emtricitabine, and tenofovir alafenamide) Tablets
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
TREMFYA®
(guselkumab) Injection, for subcutaneous use
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
XARELTO® † 1
(rivaroxaban) Tablets
$37,470
$50,730
$63,990
$77,250
$90,510
Variable – please call us for more information
YONDELIS®
(trabectedin) Injection for intravenous infusion
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
ZYTIGA®
(abiraterone acetate) Tablets
$49,960
$67,640
$85,320
$103,000
$120,680
Variable – please call us for more information
† Please see full U.S. prescribing information, including Black Box warning for:
CONCERTA®,
HALDOL®,
HALDOL® DECANOATE,
INVEGA SUSTENNA®,
INVEGA TRINZA®,
INVOKAMET®,
INVOKAMET® XR,
INVOKANA®,
PROCRIT®,
REMICADE®,
RISPERDAL CONSTA®,
SIMPONI®,
SIMPONI ARIA®,
SPORANOX®,
SPORANOX® ORAL SOLUTION,
XARELTO®
1 These products are also available for hospital outpatients in our Hospital Access Patient Assistance Program
